These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8185889
21. [Studies on the in vitro effects of cephalothin and gentamicin, alone and in combination, on proteus mirabilis and enterococci (author's transl)]. Lode H. Infection; 1975; 3(2):83-8. PubMed ID: 1102455 [Abstract] [Full Text] [Related]
22. Coagulase-negative staphylococci in air samples from operating theatres. Kiss L, Sztroj T, Széll M. Acta Microbiol Immunol Hung; 1996; 43(1):39-46. PubMed ID: 8806942 [Abstract] [Full Text] [Related]
23. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin. Alou L, Cafini F, Sevillano D, Unzueta I, Prieto J. Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734 [Abstract] [Full Text] [Related]
24. [Antibacterial activity of urine after administration of ofloxacin for 5 days]. Drugeon H, Veyries ML, Levacher M, Garnier M, Aymard G, Giroud JP, Rouveix B. Therapie; 2000 May; 55(6):691-7. PubMed ID: 11234464 [Abstract] [Full Text] [Related]
25. Antibiotic susceptibility of coagulase-negative staphylococci isolated from goats' milk. Moroni P, Vellere F, Antonini M, Pisoni G, Ruffo G, Carli S. Int J Antimicrob Agents; 2004 Jun; 23(6):637-40. PubMed ID: 15194138 [Abstract] [Full Text] [Related]
26. Telavancin: in vitro activity against staphylococci in a biofilm model. Gander S, Kinnaird A, Finch R. J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312 [Abstract] [Full Text] [Related]
27. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci. Cafiso V, Messina C, Santagati M, Campanile F, Bonfiglio G, Stefani S. Drugs Exp Clin Res; 2001 Aug; 27(3):107-11. PubMed ID: 11447768 [Abstract] [Full Text] [Related]
28. In vitro activity of deferoxamine against Porphyromonas gingivalis. Moon JH, Herr Y, Kim SW, Lee JY. FEMS Microbiol Lett; 2011 Oct; 323(1):61-7. PubMed ID: 22092680 [Abstract] [Full Text] [Related]
30. [Deferoxamine protects against gentamicin ototoxicity]. Chen Y, Wang J, Huang W. Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 34(3):154-6. PubMed ID: 12764806 [Abstract] [Full Text] [Related]
32. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Cha R. Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108 [Abstract] [Full Text] [Related]
35. Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders. Debbia EA, Dolcino M, Marchese A, Piazzi A, Berio A. New Microbiol; 2004 Oct; 27(4):361-7. PubMed ID: 15646050 [Abstract] [Full Text] [Related]
36. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers. Ponte C, Gracia M, Giménez MJ, Aguilar L, Maín CM, Carpintero Y, Huelves L, Carcas A, del Prado G, Soriano F. Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483 [Abstract] [Full Text] [Related]
37. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Tan TY, Ng SY, Teo L, Koh Y, Teok CH. J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079 [Abstract] [Full Text] [Related]
38. Inhibition of growth of Proteus mirabilis and Escherichia coli in urine in response to fasting and vegetarian diet. Kjeldsen-Kragh J, Kvaavik E, Bottolfs M, Lingaas E. APMIS; 1995 Nov; 103(11):818-22. PubMed ID: 8546847 [Abstract] [Full Text] [Related]